Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-946-7 | CAS number: 54060-92-3
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: dermal
Administrative data
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 1981
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Meets generally accepted scientific standards and is described in sufficient detail. Comparable to guideline study.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 981
- Report date:
- 1981
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 402 (Acute Dermal Toxicity)
- Deviations:
- yes
- Remarks:
- : 3 instead of 5 animals per dose
- GLP compliance:
- no
- Test type:
- standard acute method
- Limit test:
- no
Test material
- Reference substance name:
- 2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium methyl sulphate
- EC Number:
- 258-946-7
- EC Name:
- 2-[[(4-methoxyphenyl)methylhydrazono]methyl]-1,3,3-trimethyl-3H-indolium methyl sulphate
- Cas Number:
- 54060-92-3
- Molecular formula:
- C20H24N3O.CH3O4S C21H27N3O5S
- IUPAC Name:
- 2‐{[2‐(4‐methoxyphenyl)‐2‐methylhydrazin‐1‐ylidene]methyl}‐1,3,3‐trimethyl‐3H‐indol‐1‐ium methyl sulfate
- Details on test material:
- - Name of test material (as cited in study report): Basacryl-Goldgelb X-GFL konz.
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: WIGA, Sulzfeld, Germany
- Age at study initiation: no data
- Weight at study initiation: 233 g (males), 184 g (females)
- Housing: no data
- Diet (e.g. ad libitum): ad libitum
- Water (e.g. ad libitum): ad libitum
- Acclimation period: no data
ENVIRONMENTAL CONDITIONS: no data
Administration / exposure
- Type of coverage:
- occlusive
- Vehicle:
- water
- Details on dermal exposure:
- TEST SITE
- Area of exposure: 50 cm²
- Cover: inert plastic film
REMOVAL OF TEST SUBSTANCE
- Washing (if done): with tempered water
- Time after start of exposure: 24 h
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg (50% concentration), 1000 mg/kg (50% concentration, 400 mg/kg (50% concentration), 200 mg/kg (25% concentration) and 100 mg/kg (25% concentration)
- Duration of exposure:
- 24 hours
- Doses:
- 2000, 1000 and 400 mg/kg bw (test item concentration: 50% in water); 200 and 100 mg/kg bw (test item concentration: 25% in water)
- No. of animals per sex per dose:
- 3
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Investigations: Mortality, clinical signs, local effects
- Necropsy performed: yes - Statistics:
- N.A.
Results and discussion
- Preliminary study:
- N.A.
Effect levels
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- ca. 2 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- see table 1 in section "any other information on results incl. tables"
- Clinical signs:
- other: Systemic clinical signs: dyspnea, apathia, excitation, ataxia, spastic gait and poor general condition
- Gross pathology:
- Dead animals: heart: acute hyperemia; stomach organs, fat tissue/musculature: substance-related discoloration
Surviving animals: no effects - Other findings:
- N.A.
Any other information on results incl. tables
Table 1: Mortality | |||||||
Dose (mg/kg bw) |
Concentration (%) |
Animal number | found dead within | ||||
1 hour | 24 hours | 48 hours | 7 days | 14 days | |||
2000 | 50 | 3m | 0/3 | 0/3 | 1/3 | 1/3 | 1/3 |
3f | 0/3 | 2/3 | 2/3 | 2/3 | 2/3 | ||
1000 | 50 | 3m | 0/3 | 0/3 | 1/3 | 0/3 | 0/3 |
3f | 0/3 | 1/3 | 1/3 | 1/3 | 1/3 | ||
400 | 50 | 3m | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 |
3f | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 | ||
200 | 25 | 3m | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 |
3f | 0/3 | 1/3 | 1/3 | 1/3 | 1/3 | ||
100 | 25 | 3m | 0/3 | 0/3 | 0/3 | 0/3 | 0/3 |
3f | 0/3 | 1/3 | 1/3 | 1/3 | 1/3 |
Applicant's summary and conclusion
- Interpretation of results:
- not classified
- Remarks:
- Migrated information Criteria used for interpretation of results: EU
- Conclusions:
- The dermal LD50 in male and female rats is approx. 2000 mg/kg bw based on a product containing 75% of the test item. The corrected LD50 is approx. 1500 mg/kg.
- Executive summary:
In an acute dermal toxicity study Sprague Dawley rats (3 males and 3 females per dose group) were dermally exposed to a product containing 75% of the test item in water for 24 hours to 50 cm² of body surface area at 2000, 1000, 400, 200 and 100 mg/kg bw. Animals were observed for a total of 14 days. The animals showed the following systemic clinical signs: dyspnea, apathia, excitation, ataxia, spastic gait and poor general condition. Two females and one male animal of the high dose group died during the observation period. Furthermore, one female animal of the dose groups 100, 200 and 1000 mg/kg bw was found dead within the 14 days. Gross pathology of animals found dead showed an acute hyperemia of the heart and a substance-related discoloration of the stomach, fat tissue and of the musculature. Animals survived the entire observation period showed no treatment related effects at gross pathology observations. Based on the results obtained, the dermal LD50 value of the product in rats was established to be approx. 2000 mg/kg body weight for both sexes. Based on the test item (75%), the corrected LD50 is approx. 1500 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.